CLDN5 and Alzheimer disease: Hüls et al. conducted a study on the association between brain DNA methylation and cognitive trajectory in AD subjects and found that methylation of CLDN5, a protein-coding gene regulating the permeability of the blood–brain barrier, is associated with cognitive trajectory.